Figure 5From: Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model Western blot of Cyclin G2. Western blot was performed as described in Materials and Methods and shows the presence of Cyclin G2 (CCNG2) protein in LNCaP cells control or treated with 1 μM Casodex for 5 weeks. Lane 1, LNCaP-R control. Lane 2, LNCaP-R treated 5 weeks in 1 μM Casodex. Lane 3, LNCaP-UR control. Lane 4, LNCaP-UR treated 5 weeks in 1 μM Casodex.Back to article page